Your session is about to expire
← Back to Search
Peripheral Nerve Stimulation for Shoulder Impingement Syndrome
Study Summary
This trial will test a new pain relief method for those with shoulder pain caused by subacromial impingement syndrome.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a bleeding disorder that is not under control.I can check my skin and change dressings by myself or with help.I have a bone fracture in the same arm as my condition.My worst pain in the last week was 4 or more on a scale of 0 to 10.I am on a stable dose of pain medication, not exceeding one opioid or one non-opioid.You are allergic to tape or adhesive.I haven't had a steroid shot or pain treatment in my shoulder in the last 3 months.My immune system is weak due to a condition or medication.I have a shoulder injury on the same side caused by a severe accident or assault.I experience chronic pain in another part of my body almost daily.I do not have a shoulder or skin infection, nor do I need antibiotics for any bacterial infection.I have had shoulder pain for more than 3 months.I have had surgery on the same side shoulder joint before.You are currently receiving worker's compensation for a shoulder injury on the same side as the study.You currently have a device implanted in your body, like a pacemaker or deep brain stimulation system, that may interfere with the study device.I have severe shoulder pain and instability confirmed by a doctor.I have had an amputation above the wrist on one side, not including just a single finger.My doctor recommends surgery for my shoulder condition.I am 21 years old or older.I have a nerve condition affecting my arm on the same side.
- Group 1: Non Contracting Producing Peripheral Nerve Stimulation
- Group 2: Contraction Producing Peripheral Nerve Stimulation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals is this research project accepting as participants?
"Affirmative. The clinical trial information available on clinicaltrials.gov reveals that this study, which was initially posted in March of 2019, is still actively recruiting participants. 116 patients need to be sourced from two different research sites."
Are there any new opportunities to participate in this research?
"Absolutely. According to the information on clinicaltrials.gov, this medical trial is presently enrolling applicants and has been doing so since March 1st 2019 when it was initially posted. As of October 27th 2022, 116 patients are needed from two different sites for successful completion of the experiment."
Does this research accept elderly participants?
"This study has an age range from 21 to 100; any individuals outside of this bracket are ineligible for participation."
Who is able to submit applications for this research study?
"In this clinical trial, 116 people aged 21-100 are being enrolled who suffer from shoulder pain that has lasted for a minimum of 3 months. To be considered eligible, candidates must have reported 4 or higher on the 0-10 scale when asked to rate their worst pain in the past week and demonstrate either independent ability or support for managing skin care and dressing changes as well as stable analgesic intake (no more than one opioid/nonopioid)."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger